Scopus Eşleşmesi Bulundu
2
Atıf
13
Cilt
523-530
Sayfa
Özet
Background: The present dosimetric study aimed to evaluate the dosimetric benefits of using three-dimensional conformal radiotherapy (3D-CRT), dynamic intensity-modulated radiation therapy (D-IMRT), and Hybrid CRT/IMRT plans. Method: In this dosimetric research, 10 patients with locally advanced lung cancer (Stage-IIIB) were selected. The patients with centrally located tumors were particularly chosen to underline the complexity of the treatment plans. We performed 3D-CRT, D-IMRT, and Hybrid CRT/IMRT treatment plans using Varian with the Eclipse treatment planning system. The treatment plans were compared with respect to the doses received by the organs at risk, including total lungs, contralateral lung, ipsilateral lung, heart, spinal cord, esophagus, the dose homogeneity index, and conformity indexes. Paired samples t-test was performed for statistical analyses. Results: Hybrid method significantly advanced the target conformity index when compared with 3D-CRT and D-IMRT methods (P = 0.000). The total lung volume receiving 5 to 10 Gy was significantly lower in the 3D-CRT plans compared with that in D-IMRT and Hybrid plans (P = 0.025 and P = 0.003). V20 of the total lung was significantly lower in Hybrid plans (P =0.036). The average mean doses to heart in all the plans were similar with no significant differences. There was a statistically significant difference concerning the maximum doses for spinal cord, when D-IMRT plans were compared with 3D-CRT and Hybrid (P = 0.000). Conclusion: Hybrid technique could be highly conducive to the treatment, while 3D-CRT and D-IMRT techniques are not adequate alone for maintaining the spinal cord, heart, and esophagus in the treatment of LALC patients.
Web of Science Eşleşmesi Bulundu
1
WoS Atıf
13
Cilt
Article
Belge Türü
Kaynak: MIDDLE EAST JOURNAL OF CANCER
· s. 523-530
Anahtar Kelimeler (WoS)
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 2.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi Bilgisi
Otomatik ISSN Eşleştirmesi
2022 yılı verileri
Middle East Journal of Cancer
Q4
SJR Quartile
0,172
SJR Skoru
12
H-Index
🔓
Açık Erişim
Kategoriler: Cancer Research (Q4) · Oncology (Q4)
Alanlar: Biochemistry, Genetics and Molecular Biology · Medicine
Ülke: Iran
· Shiraz University of Medical Sciences
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir.
Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.
Anahtar Kelimeler
WoS |
Bir kelimeye tıklayıp ilgili kaynaktaki yayınları görün.
Makale Bilgileri
Dergi
Middle East Journal of Cancer
ISSN
2008-6709
Yıl
2022
/ 7. ay
Cilt / Sayı
13
/ 3
Sayfalar
523 – 530
Makale Türü
Özgün Makale
Hakemlik
Hakemli
Endeks
ESCI
Yayın Dili
İngilizce
Kapsam
Uluslararası
Toplam Yazar
4 kişi
Erişim Türü
Elektronik
Alan
Sağlık Bilimleri Temel Alanı
Sağlık Fiziği
YÖKSİS Yazar Kaydı
Yazar Adı
BAŞARAN HAMİT,İNAN GÖKÇEN,GÜL OSMAN VEFA,DÜZOVA MÜRSEL
YÖKSİS ID
6353108